Although seborrheic dermatitis is very common, you should offer an HIV test in the event of sudden onset, or unusual or therapy-resistant presentations. European research found an HIV prevalence of 2% in patients presenting with seborrheic dermatitis 1 and European guidance strongly recommends offering an HIV test to these patients. Recent onset of seborrheic dermatitis, dry skin or itchy folliculitis raises the index of suspicion for HIV.
HIV may exacerbate pre-existing psoriasis or cause it to appear for the first time. European guidance recommends offering HIV testing when psoriasis is severe, atypical or recalcitrant. It is also important to consider the risk of pre-existing HIV infection and offer a test if in doubt, before prescribing immune-suppressive therapy for psoriasis.
Fungal:
Viral:
Bacterial:
Severe or recalcitrant presentations of the following skin conditions should also prompt consideration of HIV:
A number of cancers, including skin and genital cancers, are more common in people living with HIV than in the general population. HIV testing should be considered in patients presenting with: